<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164833">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01941797</url>
  </required_header>
  <id_info>
    <org_study_id>cro-2011perio-02-fp</org_study_id>
    <nct_id>NCT01941797</nct_id>
  </id_info>
  <brief_title>Experimental Peri-implant Mucositis in Humans</brief_title>
  <official_title>Experimental Peri-implant Mucositis in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Connecticut Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Colgate Palmolive Co.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Connecticut Health Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study. The investigators hypothesize that the peri-implant soft tissue
      response to de novo plaque accumulation is similar to that of normal gingival tissue in the
      same subjects.

      The investigators propose to conduct a controlled clinical trial to evaluate peri-implant
      soft tissue response to de novo plaque accumulation in comparison to the response of
      gingival tissue in the same subjects
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Gingival Crevicular fluid volume collected at baseline and weekly up to 9 weeks</measure>
    <time_frame>9 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>The gingival crevicular fluid ( GCF) volume is assessed using Periotron unit. The GCF volume  is strongly correlated with peri-implant mucosa and gingival inflammation.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Peri-implant Mucositis</condition>
  <condition>Gingivitis</condition>
  <arm_group>
    <arm_group_label>Peri-implant mucosa</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>periodontal mucosa</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>interruption of oral hygiene</intervention_name>
    <arm_group_label>Peri-implant mucosa</arm_group_label>
    <arm_group_label>periodontal mucosa</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Male and Female ³21 years of age.

        Oral site specific inclusion criteria:

          -  1) Presence of 2 implants in the maxillary or mandibular  arch supporting fixed
             restorations in function for at least 1 year (Test)

          -  2) Presence of 2 teeth in the corresponding position of the implant (Control); -3)
             Absence of active infections at both test and control sites

          -  4) Absence of radiographic bone loss at both test and control sites

          -  5) Pocket depth ≤4mm at both test and control sites

          -  6) must give written informed consent.

        Exclusion Criteria:

          -  1) Treatment with antibiotics for any dental or medical condition within 1 month
             before screening

          -  2) Systemic diseases that require chronic use of anti-inflammatory medications,
             antibiotics or anticoagulants

          -  3) Ongoing medications for systemic conditions initiated &lt;3 months before the start
             of the study or the requirement to take prophylactic antibiotics for invasive dental
             procedures

          -  4) Significant organ disease including impaired kidney function, heart murmur,
             rheumatic fever, bleeding disorder

          -  5) Active infectious diseases such as hepatitis, tuberculosis and HIV

          -  6) Clinically detectable caries and periodontal disease

          -  7) Tobacco use of any kind

          -  8)  Use of medications affecting periodontal status (diphenylhydantoin, cyclosporine
             etc.)

          -  9) No pregnancy or lactation or expectation to become pregnant within next 3 months.

        Participants will be excluded from the study or analysis if any of the following occur
        during the study: 1) Changes in the patient medical status or medications that met the
        exclusion criteria; 2) Use of antimicrobial rinses; 3) Use of irrigating devices; 4)
        Subject noncompliance with stent wearing during the experimental mucositis/gingivitis
        phase and/or Vitamin C use; 5) Use of anti-inflammatory drugs or antibiotics; 6) allergic
        history to common toothpaste or mouth rinse ingredients.

        Acute use of acetaminophen will be permitted.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gian Pietro Schincaglia, DDS,PhD</last_name>
    <phone>860 679 2258</phone>
    <phone_ext>2258</phone_ext>
    <email>schincaglia@uchc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Connecticut Health Center</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megyn L Clement, CDA</last_name>
      <phone>860-679-4995</phone>
      <phone_ext>4995</phone_ext>
      <email>mclement@uchc.edu</email>
    </contact>
    <investigator>
      <last_name>Gian Pietro Schincaglia, DDS,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://home2.uchc.edu/Starr/Study/Condition/Details.aspx?Condition=47</url>
    <description>University of Connecticut Health center Clinical Trials</description>
  </link>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 12, 2013</lastchanged_date>
  <firstreceived_date>September 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Connecticut Health Center</investigator_affiliation>
    <investigator_full_name>Gian Schincaglia</investigator_full_name>
    <investigator_title>Clinical Associate Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gingivitis</mesh_term>
    <mesh_term>Mucositis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
